The 36-month beta value for CLPT is at 1.02. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CLPT is 23.89M, and currently, shorts hold a 3.09% of that float. The average trading volume for CLPT on January 22, 2025 was 239.73K shares.
CLPT) stock’s latest price update
The stock price of ClearPoint Neuro Inc (NASDAQ: CLPT) has jumped by 22.47 compared to previous close of 15.04. Despite this, the company has seen a gain of 19.61% in its stock price over the last five trading days. zacks.com reported 2024-12-23 that Here are some strong MedTech stocks – DOCS, CLOV, CLPT and HIMS – that are expected to provide promising gains.
CLPT’s Market Performance
ClearPoint Neuro Inc (CLPT) has seen a 19.61% rise in stock performance for the week, with a 12.73% gain in the past month and a 52.74% surge in the past quarter. The volatility ratio for the week is 8.24%, and the volatility levels for the past 30 days are at 6.85% for CLPT. The simple moving average for the past 20 days is 18.98% for CLPT’s stock, with a 86.76% simple moving average for the past 200 days.
Analysts’ Opinion of CLPT
Many brokerage firms have already submitted their reports for CLPT stocks, with B. Riley Securities repeating the rating for CLPT by listing it as a “Buy.” The predicted price for CLPT in the upcoming period, according to B. Riley Securities is $10 based on the research report published on July 25, 2024 of the previous year 2024.
Stifel, on the other hand, stated in their research note that they expect to see CLPT reach a price target of $8. The rating they have provided for CLPT stocks is “Buy” according to the report published on October 24th, 2023.
B. Riley Securities gave a rating of “Buy” to CLPT, setting the target price at $14 in the report published on February 16th of the previous year.
CLPT Trading at 32.02% from the 50-Day Moving Average
After a stumble in the market that brought CLPT to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 5.44% of gains for the given period.
Volatility was left at 6.85%, however, over the last 30 days, the volatility rate increased by 8.24%, as shares surge +22.15% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +43.68% upper at present.
During the last 5 trading sessions, CLPT rose by +19.61%, which changed the moving average for the period of 200-days by +179.09% in comparison to the 20-day moving average, which settled at $15.48. In addition, ClearPoint Neuro Inc saw 19.77% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for CLPT
Current profitability levels for the company are sitting at:
- -0.62 for the present operating margin
- 0.6 for the gross margin
The net margin for ClearPoint Neuro Inc stands at -0.6. The total capital return value is set at -0.58. Equity return is now at value -68.36, with -43.19 for asset returns.
Based on ClearPoint Neuro Inc (CLPT), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at -2.4. The debt to equity ratio resting at 0.13. The interest coverage ratio of the stock is -98.68.
Currently, EBITDA for the company is -20.99 million with net debt to EBITDA at 1.03. When we switch over and look at the enterprise to sales, we see a ratio of 16.11. The receivables turnover for the company is 7.85for trailing twelve months and the total asset turnover is 0.76. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.54.
Conclusion
In conclusion, ClearPoint Neuro Inc (CLPT) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
